Cathrine Elgaard Jensen1, Sabrina Storgaard Sørensen2, Claire Gudex3, Morten Berg Jensen4, Kjeld Møller Pedersen5, Lars Holger Ehlers2. 1. Department of Clinical Medicine, Danish Center for Healthcare Improvements, Aalborg University, Aalborg, Denmark. cathelgaard@gmail.com. 2. Department of Clinical Medicine, Danish Center for Healthcare Improvements, Aalborg University, Aalborg, Denmark. 3. Department of Clinical Research, University of Southern Denmark and OPEN - Open Patient data Explorative Network, Odense University Hospital, Odense, Denmark. 4. Department of Economics and Business Economics, Aarhus University, Aarhus, Denmark. 5. Department of Management and Economics, University of Southern Denmark, Odense, Denmark.
Abstract
OBJECTIVES: Quality-adjusted life-years (QALYs) are expected to be used for priority setting of hospital-dispensed medicines in Denmark from 2021. The aim of this study was to develop the first Danish value set for the EQ-5D-5L based on interviews with a representative sample of the Danish adult population. METHODS: A nationally representative sample based on age (> 18 years), gender, education, and geographical region was recruited using data provided by Statistics Denmark. Computer-assisted personal interviews were carried out using the EQ-VT 2.1. Respondents each valued ten health states using composite time trade-off (cTTO) and seven health states using discrete-choice experiment (DCE). Different predictive models were explored using cTTO and DCE data alone or in combination as hybrid models. Model performance was assessed using logical consistency. RESULTS: A total of 1014 interviews were included in the analyses. The sample was representative of the Danish adult population, though the sample contained slightly more respondents with higher education than in the general population. Only the heteroscedastic censored hybrid model combining cTTO and DCE data yielded consistent results, and hence was chosen for modelling the final Danish value set. The predicted values ranged from - 0.757 to 1, and anxiety/depression was the dimension assigned most value by respondents. CONCLUSIONS: This study established the Danish EQ-5D-5L value set, which represents the preferences of the Danish general population, and is expected to provide key input for healthcare decision-making in a Danish context.
OBJECTIVES: Quality-adjusted life-years (QALYs) are expected to be used for priority setting of hospital-dispensed medicines in Denmark from 2021. The aim of this study was to develop the first Danish value set for the EQ-5D-5L based on interviews with a representative sample of the Danish adult population. METHODS: A nationally representative sample based on age (> 18 years), gender, education, and geographical region was recruited using data provided by Statistics Denmark. Computer-assisted personal interviews were carried out using the EQ-VT 2.1. Respondents each valued ten health states using composite time trade-off (cTTO) and seven health states using discrete-choice experiment (DCE). Different predictive models were explored using cTTO and DCE data alone or in combination as hybrid models. Model performance was assessed using logical consistency. RESULTS: A total of 1014 interviews were included in the analyses. The sample was representative of the Danish adult population, though the sample contained slightly more respondents with higher education than in the general population. Only the heteroscedastic censored hybrid model combining cTTO and DCE data yielded consistent results, and hence was chosen for modelling the final Danish value set. The predicted values ranged from - 0.757 to 1, and anxiety/depression was the dimension assigned most value by respondents. CONCLUSIONS: This study established the Danish EQ-5D-5L value set, which represents the preferences of the Danish general population, and is expected to provide key input for healthcare decision-making in a Danish context.
Authors: Ben van Hout; M F Janssen; You-Shan Feng; Thomas Kohlmann; Jan Busschbach; Dominik Golicki; Andrew Lloyd; Luciana Scalone; Paul Kind; A Simon Pickard Journal: Value Health Date: 2012-05-24 Impact factor: 5.725
Authors: Pedro L Ferreira; Patrícia Antunes; Lara N Ferreira; Luís N Pereira; Juan M Ramos-Goñi Journal: Qual Life Res Date: 2019-06-14 Impact factor: 4.147
Authors: M F Janssen; A Simon Pickard; Dominik Golicki; Claire Gudex; Maciej Niewada; Luciana Scalone; Paul Swinburn; Jan Busschbach Journal: Qual Life Res Date: 2012-11-25 Impact factor: 4.147
Authors: Anna Hobbins; Luke Barry; Dan Kelleher; Koonal Shah; Nancy Devlin; Juan Manuel Ramos Goni; Ciaran O'Neill Journal: Pharmacoeconomics Date: 2018-11 Impact factor: 4.981
Authors: Astrid Langergaard; Kim Mathiasen; Jesper Søndergaard; Sabrina S Sørensen; Sidsel L Laursen; Alexander A P Xylander; Mia B Lichtenstein; Lars H Ehlers Journal: Internet Interv Date: 2022-02-19
Authors: Astrid Langergaard; Sidsel Lund Laursen; Stig Helweg-Jørgensen; Jesper Søndergaard; Sabrina Storgaard Sørensen; Kim Mathiasen; Mia Beck Lichtenstein; Lars Holger Ehlers Journal: J Med Internet Res Date: 2021-11-11 Impact factor: 5.428